CN112608908B - 重组新型冠状病毒刺突蛋白受体结合区9型腺相关病毒的构建方法 - Google Patents
重组新型冠状病毒刺突蛋白受体结合区9型腺相关病毒的构建方法 Download PDFInfo
- Publication number
- CN112608908B CN112608908B CN202011556313.7A CN202011556313A CN112608908B CN 112608908 B CN112608908 B CN 112608908B CN 202011556313 A CN202011556313 A CN 202011556313A CN 112608908 B CN112608908 B CN 112608908B
- Authority
- CN
- China
- Prior art keywords
- rbd
- recombinant
- cells
- associated virus
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011556313.7A CN112608908B (zh) | 2020-12-25 | 2020-12-25 | 重组新型冠状病毒刺突蛋白受体结合区9型腺相关病毒的构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011556313.7A CN112608908B (zh) | 2020-12-25 | 2020-12-25 | 重组新型冠状病毒刺突蛋白受体结合区9型腺相关病毒的构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112608908A CN112608908A (zh) | 2021-04-06 |
CN112608908B true CN112608908B (zh) | 2023-03-21 |
Family
ID=75245222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011556313.7A Active CN112608908B (zh) | 2020-12-25 | 2020-12-25 | 重组新型冠状病毒刺突蛋白受体结合区9型腺相关病毒的构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112608908B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112921007A (zh) * | 2021-02-05 | 2021-06-08 | 华中农业大学 | 用于预防猫感染新冠病毒的重组腺相关病毒及其构建方法和应用 |
CN113913464B (zh) * | 2021-09-28 | 2022-11-22 | 武汉枢密脑科学技术有限公司 | 一种表达载体、重组腺相关病毒及其在制备2019新型冠状病毒疫苗中的应用 |
WO2023060483A1 (zh) * | 2021-10-13 | 2023-04-20 | 清华大学 | 多肽-rbd免疫偶联物及其用途 |
CN114432435A (zh) * | 2022-01-25 | 2022-05-06 | 苏州大学 | 一种基于多角体纳米结构的SARS-Cov-2疫苗及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111217917A (zh) * | 2020-02-26 | 2020-06-02 | 康希诺生物股份公司 | 一种新型冠状病毒SARS-CoV-2疫苗及其制备方法 |
CN111218459A (zh) * | 2020-03-18 | 2020-06-02 | 中国人民解放军军事科学院军事医学研究院 | 一种以人复制缺陷腺病毒为载体的重组新型冠状病毒疫苗 |
CN111996216A (zh) * | 2020-09-01 | 2020-11-27 | 中国科学技术大学 | 腺相关病毒介导的新型冠状病毒抗体诱导物及疫苗组合物 |
CN112048005A (zh) * | 2020-09-04 | 2020-12-08 | 江苏省中国科学院植物研究所 | 新型冠状病毒s蛋白片段多倍体及其制备方法、检测试剂盒、疫苗及药物 |
-
2020
- 2020-12-25 CN CN202011556313.7A patent/CN112608908B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111217917A (zh) * | 2020-02-26 | 2020-06-02 | 康希诺生物股份公司 | 一种新型冠状病毒SARS-CoV-2疫苗及其制备方法 |
CN111218459A (zh) * | 2020-03-18 | 2020-06-02 | 中国人民解放军军事科学院军事医学研究院 | 一种以人复制缺陷腺病毒为载体的重组新型冠状病毒疫苗 |
CN111996216A (zh) * | 2020-09-01 | 2020-11-27 | 中国科学技术大学 | 腺相关病毒介导的新型冠状病毒抗体诱导物及疫苗组合物 |
CN112048005A (zh) * | 2020-09-04 | 2020-12-08 | 江苏省中国科学院植物研究所 | 新型冠状病毒s蛋白片段多倍体及其制备方法、检测试剂盒、疫苗及药物 |
Non-Patent Citations (1)
Title |
---|
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation;Wang et al.;《AAPS PharmSciTech》;20200805;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN112608908A (zh) | 2021-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112608908B (zh) | 重组新型冠状病毒刺突蛋白受体结合区9型腺相关病毒的构建方法 | |
WO2021227401A1 (zh) | Sars-cov-2抗原多肽及其重组腺相关病毒和在制备疫苗中的应用 | |
EP3950947A1 (en) | Recombinant novel coronavirus vaccine using replication-deficient human adenovirus as vector | |
CN111217919B (zh) | 一种基于火球菌铁蛋白的新型冠状病毒s蛋白双区域亚单位纳米疫苗 | |
CN111560074B (zh) | 一种基于幽门螺旋杆菌铁蛋白的新型冠状病毒s蛋白单区域亚单位纳米疫苗 | |
CN111607002B (zh) | 一种基于幽门螺旋杆菌铁蛋白的新型冠状病毒s蛋白双区域亚单位纳米疫苗 | |
CN107190013B (zh) | 一种以人Ad5复制缺陷型腺病毒为载体的寨卡病毒病疫苗 | |
EP3307310A2 (en) | Aav-mediated expression of anti-influenza antibodies and methods of use thereof | |
CN109182380B (zh) | 杆状病毒表达的猪瘟e2亚单位疫苗的制备方法及应用 | |
EP4105228A1 (en) | Sars-cov-2 antigen polypeptide, recombinant adeno-associated virus thereof, and application in preparation of vaccine | |
WO2017128783A1 (zh) | 一种以人复制缺陷腺病毒为载体的埃博拉病毒病疫苗 | |
CN113913464B (zh) | 一种表达载体、重组腺相关病毒及其在制备2019新型冠状病毒疫苗中的应用 | |
WO2022032496A1 (zh) | 一种预防新型冠状病毒微颗粒的制备方法及应用 | |
US20230090422A1 (en) | Novel coronavirus s protein double-region subunit nano-vaccine based on bacterial complex | |
CN108148816B (zh) | 一种不受泛素化蛋白酶体降解的突变pcv2病毒及其制备方法和应用 | |
CN117551677A (zh) | 一种以5型腺病毒为载体的猴痘病毒特异性融合蛋白疫苗 | |
CN105859891B (zh) | Gfp-cd19融合蛋白及其在细胞标记方面的应用 | |
CN102925485B (zh) | 双表达的aav重组病毒的制备方法 | |
CN113637695B (zh) | 靶向刺激体液免疫和细胞免疫的新冠病毒mRNA疫苗 | |
CN113248577B (zh) | 一种以腺病毒为载体的冠状病毒疫苗及其制备方法 | |
WO2021036245A1 (zh) | 携带安全开关并靶向EGFRvⅢ的嵌合抗原受体T细胞及其制备方法和应用 | |
CN113416713A (zh) | 一种重组腺病毒的构建及其应用 | |
CN112390860A (zh) | Eb病毒抗原表位及其应用 | |
LU503210B1 (en) | A live vector vaccine of Baculovirus based on SARS-CoV-2 S protein and the application | |
CN115819522B (zh) | 一种带状疱疹病毒疫苗、表达蛋白及重组腺病毒制备与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Rao Chunming Inventor after: Yu Lei Inventor after: Zhou Yong Inventor after: Guo Ying Inventor after: Han Chunmei Inventor after: Zhu Liuqiang Inventor after: Qin Xi Inventor after: Li Yonghong Inventor after: Li Shanhu Inventor after: Li Xiang Inventor after: Ding Youxue Inventor after: Pei Dening Inventor after: Liu Lan Inventor after: Shi Xinchang Inventor before: Wang Junzhi Inventor before: Shi Xinchang Inventor before: Yu Lei Inventor before: Zhou Yong Inventor before: Guo Ying Inventor before: Han Chunmei Inventor before: Zhu Liuqiang Inventor before: Rao Chunming Inventor before: Qin Xi Inventor before: Li Yonghong Inventor before: Li Shanhu Inventor before: Li Xiang Inventor before: Ding Youxue Inventor before: Pei Dening Inventor before: Liu Lan |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |